Market revenue in 2023 | USD 3,283.9 million |
Market revenue in 2030 | USD 5,526.2 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Biobanking equipment |
Fastest growing segment | LIMS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 74.8% in 2023. Horizon Databook has segmented the Brazil biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is one of the most economically developed countries in Latin America and its market is expected to grow at a significant rate in the coming years. Moreover, the healthcare sector has been historically driving the Brazilian economy and a strong consumer-based market makes the country.
An attractive ground for introduction of new products & services in biobanking. Brazil also leads Latin America with the most patent applications and trademark registrations which demonstrates the research and development capabilities of the country.
The major biobanks players in the country include the Biobank of the A C Camargo Cancer Center (A C Camargo Biobank), Brazilian National Tumor and DNA Bank (BNT-INCA), and Banco de Tumores Ricardo Renzo Brentani.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biobank market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account